Press release
AI in Drug Manufacturing Market to Reach USD 6.94 Billion by 2030 as Pharma Digitalization, Predictive Quality Control & Autonomous GMP Plants Expand
AI in Drug Manufacturing Market
Introduction
The AI in Drug Manufacturing Market is undergoing a major digital transformation as pharmaceutical companies accelerate adoption of artificial intelligence, machine learning, predictive analytics, and robotics to increase productivity, enhance compliance, reduce batch failures, and streamline complex bioprocessing operations.
AI is now being deployed across:
• Continuous manufacturing systems
• Bioreactor monitoring & optimization
• API synthesis automation
• Predictive quality control (eQMS + real-time analytics)
• Supply chain planning & inventory intelligence
• Digital twins for vaccine, biologics & cell therapy production
• Automated sterile manufacturing (fill-finish)
• AI-driven equipment maintenance & anomaly detection
As pharma companies push for next-generation manufacturing readiness, AI is becoming foundational to the future of global GMP operations.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73669
Key Takeaways
• Market Size (2023): USD 2.41 Billion
• Market Size (2030): USD 6.94 Billion
• CAGR (2024-2030): 16.5%
• Over 72% of global pharma companies implemented AI pilots in manufacturing by 2024.
• Key players include Pfizer, Novartis, Merck, Bayer, Sanofi, AstraZeneca, Takeda, GSK, Roche, and AI integrators such as Siemens, Honeywell, IBM, Rockwell, Schneider Electric, Cognex, and ABB.
• High adoption seen in biologics, ADCs, mRNA vaccines, viral vector manufacturing, and small-molecule continuous processes.
Market Story
AI is reshaping pharmaceutical manufacturing through end-to-end automation, intelligent process control, and predictive decision-making.
1. AI-Driven Bioprocess Optimization for Biologics & Vaccines
AI improves:
• Bioreactor feed strategies
• Cell culture productivity
• Real-time nutrient monitoring
• Yield prediction
• Protein expression optimization
This is critical for mAbs, biosimilars, ADCs, and vaccine batches.
2. Digital Twins Transform GMP Operations
Use cases include:
• Simulating manufacturing lines
• Predicting batch failures
• Optimizing clean-room airflow
• Modeling sterile fill-finish operations
• Reducing scale-up timelines
Digital twins reduce experimentation cycles by 30-50%.
3. Predictive Quality Control Reduces Batch Rejection
AI supports:
• Real-time deviation prediction
• Multivariate analysis for quality attributes
• Automated OOS/OOT (Out-of-Spec/Out-of-Trend) alerts
• Automated compliance documentation
This lowers batch-failure rates by up to 40%.
4. Autonomous & Robotics-Assisted Manufacturing
Pharma companies are deploying:
• Robotic arms for fill-finish
• Automated AGVs for GMP logistics
• AI-based visual inspection systems
• Cleaning robot systems in sterile suites
These reduce human error, contamination risk, and compliance burden.
5. AI in API & Small-Molecule Manufacturing
AI enables:
• Catalyst optimization
• Reaction pathway prediction
• Continuous API manufacturing control
• Solvent recovery optimization
APIs and HPAPIs benefit from automated, closed-loop systems.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73669/ai-in-drug-manufacturing-market
Market Segments
By Application
• Process Optimization & Control
• Predictive Maintenance & Monitoring
• Quality Control (AI-QC)
• Digital Twins & Simulation
• Supply Chain & Inventory Intelligence
• Automated Documentation & Compliance
• Robotics & Smart Equipment
By Process Type
• Biologics Manufacturing
• Small-Molecule Manufacturing
• Vaccine Production (mRNA, viral vectors)
• Cell & Gene Therapy (CGT)
• Fill-Finish Sterile Operations
By Technology
• Machine Learning & Deep Learning
• Computer Vision
• Natural Language Processing (NLP)
• Reinforcement Learning
• Robotics & Automation
• Digital Twin Platforms
By End User
• Pharmaceutical Companies
• Biotechnology Companies
• CDMOs & CMOs
• Research & Academic Institutes
By Region
• North America - fastest adoption
• Europe - strong regulatory tech modernization
• Asia-Pacific - highest CAGR (growth in biologics/CDMO sites)
• Middle East & Latin America - early adoption phase
Recent Developments
• Pfizer deployed AI-enabled predictive QMS across multiple GMP facilities.
• Novartis integrated digital twins for continuous manufacturing optimization.
• Merck expanded its BioContinuum AI platform for bioprocess automation.
• Sanofi launched "Factory of the Future" projects using robotics + AI.
• AstraZeneca adopted AI-driven supply chain forecasting in oncology manufacturing.
• Roche implemented AI-based visual inspection in sterile injectables.
• Siemens & Honeywell rolled out advanced AI control systems for biologics plants.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73669
Expert Quote
"AI is becoming the backbone of modern pharmaceutical manufacturing, enabling real-time optimization, predictive quality, and autonomous plant operations. The shift toward digital GMP environments will define the next decade of pharma competitiveness."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Rising complexity of biologics & cell therapies
• Need to reduce cost, variability & batch failures
• Strong regulatory push for digitalization (FDA, EMA, MHRA)
• Expansion of global CDMO capacity
• Adoption of digital twins & autonomous clean-room technologies
• Workforce shortages driving automation demand
Forecast Outlook
The AI in Drug Manufacturing Market will surpass USD 6.94 billion by 2030, driven by:
• Widespread adoption of digital twin architecture
• Growth in robotics-assisted sterile manufacturing
• Integration of AI into PAT (Process Analytical Technology) frameworks
• Expansion of high-volume biologics and mRNA production lines
Regional Highlights
• U.S. leads due to innovation-friendly regulatory environment
• EU advances digital GMP readiness through advanced automation standards
• China & India accelerating AI adoption in CDMO/manufacturing clusters
• Middle East investing in next-gen pharma ecosystems (Saudi Vision 2030, UAE Pharma Hub)
Government & Regulatory Initiatives
• FDA's "Advancing Digital Quality Systems" roadmap
• EMA's digital transformation initiative for GMP
• National incentives for Industry 4.0 and smart manufacturing
• Government-backed AI programs in U.S., Europe, China, Japan, Singapore, GCC
• Investment incentives for CDMOs adopting AI-driven systems
Conclusion
AI is revolutionizing drug manufacturing through predictive analytics, autonomous control, and digital GMP operations. Companies adopting AI-first manufacturing strategies will outperform in efficiency, quality, and global competitiveness.
This report is also available in the following languages : Japanese (医薬品製造市場におけるAI), Korean (약물 제조 시장의 AI), Chinese (人工智能在药品制造市场), French (L'IA sur le marché de la fabrication de médicaments), German (KI im Markt für Arzneimittelherstellung), and Italian (L'intelligenza artificiale nel mercato della produzione farmaceutica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73669
Our More Reports:
Clinical Trial Software Market
https://exactitudeconsultancy.com/reports/73711/clinical-trial-software-market
Pharma Cloud Services Market
https://exactitudeconsultancy.com/reports/73713/pharma-cloud-services-market
AI in Medical Imaging Market
https://exactitudeconsultancy.com/reports/73715/ai-in-medical-imaging-market
AI in Clinical Trials Market
https://exactitudeconsultancy.com/reports/73717/ai-in-clinical-trials-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Drug Manufacturing Market to Reach USD 6.94 Billion by 2030 as Pharma Digitalization, Predictive Quality Control & Autonomous GMP Plants Expand here
News-ID: 4295389 • Views: …
More Releases from Exactitude Consultancy
Emerging Pharma & Healthcare Markets to Reach USD 1.72 Trillion by 2030 as Asia- …
Sub-Headline: The Emerging Pharma & Healthcare Market across Asia-Pacific, Latin America, Middle East, Africa, and Eastern Europe is projected to grow from USD 982 billion in 2023 to USD 1.72 trillion by 2030, registering a strong CAGR of 8.3%, driven by rising healthcare spending, rapid regulatory modernization, booming generics & biologics production, and digital-health adoption.
Introduction
The Emerging Pharma & Healthcare Market is entering a high-growth decade as countries across Asia-Pacific, LATAM,…
New Drug Approvals & Contract Manufacturing Market to Reach USD 87.3 Billion by …
Sub-Headline: The global market for newly approved drugs and their contract manufacturing services is projected to grow from USD 54.6 billion in 2023 to USD 87.3 billion by 2030, reflecting a strong CAGR of 7.0%, driven by rapid approvals of biologics, antibody-drug conjugates (ADCs), mRNA vaccines, cell & gene therapies, and the rising outsourcing needs of pharmaceutical innovators.
Introduction
The New Drug Approvals and Their Contract Manufacture Market is entering a high-growth…
Pharma M&A Deals Surge to USD 82.6 Billion in Q2 2025 as Big Pharma Accelerates …
Sub-Headline: Global pharmaceutical M&A deal value increased from USD 64.2 billion in Q2 2024 to USD 82.6 billion in Q2 2025, reflecting a strong 28.6% YoY growth, driven by strategic acquisitions in oncology, gene therapy, immunology, and AI-enabled drug development platforms.
Introduction
The M&A Trends in Pharma - Q2 2025 Market analysis reveals a high-momentum quarter, with pharmaceutical giants aggressively acquiring biotech innovators to strengthen clinical pipelines, expand therapeutic portfolios, and accelerate…
Immuno-Oncology Market to Reach USD 196.4 Billion by 2030,registering a strong C …
Sub-Headline: The global Immuno-Oncology Market is projected to grow from USD 92.3 billion in 2023 to USD 196.4 billion by 2030, registering a strong CAGR of 11.5%, driven by rapid expansion of checkpoint inhibitors, CAR-T therapies, tumor microenvironment modulators, and next-generation individualized cancer vaccines.
Introduction
The Immuno-Oncology (IO) Market continues to dominate global cancer therapeutics, transforming patient outcomes through precision-driven, immune-based treatments. IO therapies-including immune checkpoint inhibitors (ICI), CAR-T cell therapy, bispecific…
More Releases for Manufacturing
Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and…
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Global Miscellaneous Market overview
Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs.
Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing…
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,…
Additive & Conventional Manufacturing – Hybrid Manufacturing Techniques From C …
Croft Filters, based in Warrington, England, have been supplying custom filtration and separation solutions for over 31 years. Over this time, Croft has developed a reputation for their quality, bespoke service through manufacturing a variety of products for specific requirements. These products have included Filtration Cones, Baskets & Screens, Disc Filters and Filtration Housings amongst others, and they are made with Wire Mesh, Wedge Wire and Perforated Plate, depending on…
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure.
Major Companies Covered in this report:-
Al-Jon Manufacturing
Heitman Laboratories
Kws Manufacturing Company
Kmb Systems
Obvius Holdingd Llc
Lubecorp Manufacturing
Quadlogic…
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this…
